Literature DB >> 16180807

Cyanopeptolin 954, a chlorine-containing chymotrypsin inhibitor of Microcystis aeruginosa NIVA Cya 43.

Eric von Elert1, Lukas Oberer, Petra Merkel, Thomas Huhn, Judith F Blom.   

Abstract

A new depsipeptide, cyanopeptolin 954 (1), was isolated from the freshwater cyanobacterium Microcystis aeruginosa NIVA Cya 43. The structure of the compound was elucidated by chemical and spectroscopic analyses, including 2D NMR and GC-MS of the hydrolysate. The major structural differences compared to previously characterized heptadepsipeptides of Microcystis are the replacement of the basic amino acid in position 4 by L-leucine, the presence of L-phenylalanine in position 6, and the uncommon residue 3'-chloro-N-Me-L-tyrosine in position 7. Cyanopeptolin 954 inhibited chymotrypsin with an IC50 value of 45 nM. Nostopeptin BN920, formerly isolated from the cyanobacterium Nostoc,(1) was isolated from the same strain of Microcystis, and a cis amide bond between Phe (6) and N-Me-Tyr (7) was shown. Nostopeptin BN920 inhibited chymotrypsin with an IC50 value of 31 nM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16180807     DOI: 10.1021/np050079r

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  18 in total

1.  Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp.

Authors:  Roger G Linington; Daniel J Edwards; Cynthia F Shuman; Kerry L McPhail; Teatulohi Matainaho; William H Gerwick
Journal:  J Nat Prod       Date:  2007-12-29       Impact factor: 4.050

2.  Cyanobacterial protease inhibitors lead to maternal transfer of increased protease gene expression in Daphnia.

Authors:  Anke Schwarzenberger; Eric Von Elert
Journal:  Oecologia       Date:  2012-09-29       Impact factor: 3.225

Review 3.  Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery.

Authors:  George E Chlipala; Shunyan Mo; Jimmy Orjala
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

4.  Depsipeptides from a Guamanian Marine Cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases.

Authors:  Brent K Rubio; Stephen M Parrish; Wesley Yoshida; Peter J Schupp; Tom Schils; Philip G Williams
Journal:  Tetrahedron Lett       Date:  2010-12-22       Impact factor: 2.415

5.  Gene expression and activity of digestive proteases in Daphnia: effects of cyanobacterial protease inhibitors.

Authors:  Anke Schwarzenberger; Anja Zitt; Peter Kroth; Stefan Mueller; Eric Von Elert
Journal:  BMC Physiol       Date:  2010-05-04

6.  Homotyrosine-containing cyanopeptolins 880 and 960 and anabaenopeptins 908 and 915 from Planktothrix agardhii CYA 126/8.

Authors:  Hilary S Okumura; Benjamin Philmus; Cyril Portmann; Thomas K Hemscheidt
Journal:  J Nat Prod       Date:  2009-01       Impact factor: 4.050

Review 7.  Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Mark T Hamann
Journal:  Biochim Biophys Acta       Date:  2009-03-19

8.  Interspecific differences between D. pulex and D. magna in tolerance to cyanobacteria with protease inhibitors.

Authors:  Christian J Kuster; Eric Von Elert
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

9.  Lyngbyastatins 8-10, elastase inhibitors with cyclic depsipeptide scaffolds isolated from the marine cyanobacterium Lyngbya semiplena.

Authors:  Jason C Kwan; Kanchan Taori; Valerie J Paul; Hendrik Luesch
Journal:  Mar Drugs       Date:  2009-11-03       Impact factor: 5.118

10.  Halogenase genes in nonribosomal peptide synthetase gene clusters of Microcystis (cyanobacteria): sporadic distribution and evolution.

Authors:  Sabrina Cadel-Six; Catherine Dauga; Anne Marie Castets; Rosmarie Rippka; Christiane Bouchier; Nicole Tandeau de Marsac; Martin Welker
Journal:  Mol Biol Evol       Date:  2008-07-08       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.